Episode Details

We explore the Quality Management System requirements for medical device manufacturers in six key Southeast Asian markets: Singapore, Malaysia, Vietnam, the Philippines, Thailand, and Indonesia. The episode details the mandatory ISO 13485 standard and clarifies where the Medical Device Single Audit Program (MDSAP) is, and importantly, where it isn't, a valid substitute for market access. Key Questions: • What is the fundamental difference between ISO 13485 and an MDSAP audit? • Is ISO 13485 certification mandatory for all major Southeast Asian markets? • Which Southeast Asian country officially accepts MDSAP audit reports? • What does it mean for a country to be an "Official Observer" of the MDSAP program? • When does Singapore's new rule regarding MDSAP acceptance come into effect? • For which markets is MDSAP not a direct substitute for ISO 13485? • How does the ASEAN Medical Device Directive (AMDD) influence these regulations? • Is pursuing an MDSAP audit a cost-effective strategy if you're only targeting Southeast Asia? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email info@pureglobal.com for tailored support.